Linda Bowen

Linda has 35 years-experience in the BioPharma Industry, of which 25 years were spent in regulatory affairs. She is Head of Regulatory Policy and Intelligence at Seattle Genetics and is an Assistant Professor in the Temple University RAQA Program. She was previously Head of US Regulatory Policy & Intelligence at Sanofi and held regulatory positions at Bayer and GSK. Linda is Chair of the DIA Regulatory Affairs Community and founder of the DIA Regulatory Intelligence Working Group. She was previously honored with the DIA’s 2012 Excellence in Volunteer Leadership Award. She is a past two-term member of the RAPS Board of Directors, Chair of the NJ/NY RAPS Chapter, and a RAPS Fellow. She is Program Chair for the 2019 RAPS Annual Convergence